UKMEC lupus antiphospholipid antibodies — DFSRH MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — UKMEC 4
SLE with positive antiphospholipid antibodies makes CHC an unacceptable thrombotic risk. Disease quiescence does not remove the antiphospholipid-related contraindication. Non-oestrogen options should be considered, taking account of thrombocytopenia and bleeding risks.
Reference: FSRH UKMEC; FSRH Combined Hormonal Contraception